28
Jan

Merck skated through an FDA panel for its latest oral immunotherapy for allergies, as a group of agency advisers found the drug to be safe and effective for counteracting ragweed pollen.

…read more

Source: Merck’s allergy pill sways an FDA panel but faces a long road to success

    

0 No comments